摘要
目的探讨联合用药治疗慢性乙型肝炎的疗程与疗效。方法回顾我院2000年来接受抗病毒治疗中的190例慢性乙肝患者,将其分为两组,予干扰素联合α1胸腺肽抗病毒治疗,治疗组用药一年,对照组用药半年,观察疗效。结果二者总有效率及复发率存在显著差异。结论干扰素联合α1胸腺肽治疗慢性乙肝有良好疗效,且与治疗时间正相关。
Objective： To analyze the relationship between the course and the effect of chronic hepatitis B joint - medication. Methods： 190 chronic hepatitis patients from our hospital since the year 2000 were reviewed, divided into two groups, and given joint antivirus treatment of interferon and thymopetide α1, with Treatment Group one year medication while Control Group half a year. Results： There were significant differences in total effective and recurrence ratios between the two groups. Conclusions： The combined treatment of chronic hepatitis B was interferon and thymopetide α1 possess good effect, and has positive correlation with therapeutic time.
出处
《华西医学》
CAS
2006年第2期282-282,共1页
West China Medical Journal
关键词
干扰素
胸腺肽
慢性乙型肝炎
interferon
thymopeptide
chronic hepatitis B
